Notícias

SpaceX's post-IPO pullback comes as Starlink profits rise, AI revenues surge and Starship advances toward an orbital test.

Investing.com -- Jefferies initiated coverage of Braveheart Bio with a Buy rating and a $48 price target, implying roughly 75% upside from the stock’s prior closing price. The move comes after the company priced its initial public offering (IPO) at $18 per share earlier this month, raising $382.5 million in one of the largest biotech debuts of 2026.

AI could accelerate X-Energy's path toward commercial nuclear power.

Next-generation nuclear reactors need fuel, and Standard Nuclear is one of the companies that provides it.

Solstice Advanced Materials (NASDAQ:SOLS) jumped by 12.76 percent on Friday to finish at $63.53 apiece after abandoning a plan to acquire Element Solutions for $14.5 billion, while investors also cheered a $500 million share buyback program. In a statement, the company said that it entered into an agreement with Element Solutions to formally terminate their […]

On August 10, gold mining giants Barrick Mining Corporation (NYSE:B) and Newmont Corporation (NYSE:NEM) reached a landmark agreement to resolve all outstanding disputes regarding their Nevada Gold Mines (NGM) joint venture. Under the deal, previously excluded properties, Barrick’s high-grade Fourmile project and Newmont’s Fiberline and Mike developments, will be contributed directly into NGM. To reflect […]

Walmart tops the biggest IPO returns list, turning $1,000 into $38.9 million. See where SpaceX and Nvidia rank.

Shares of Solstice Advanced Materials soared early Friday after the company called off a dramatic acquisition that would have turned the company into even more of an AI play. In early July, Solstice announced a cash and stock deal to buy Element Solutions Element makes products used in semiconductor manufacturing. Together, the companies would supply three legs of the AI value chain: The chips, the data centers, and the power that makes everything work.

Tempus AI, Inc. (NASDAQ:TEM) rallied following a melanoma breakthrough reported by Moderna and Merck. The companies said their Phase 3 INTerpath-001 trial met its recurrence-free survival endpoint for the personalized cancer therapy intismeran autogene, also known as V940, combined with Keytruda. Detailed trial data remain pending. The read-through came from Personalis, which has supported the […]

JPMorgan may accept some insiders’ SpaceX shares as loan collateral before its customary 135-day waiting period.

A fund that invests in international companies that went public in the past few years is beating its U.S. counterpart. Japan’s Kioxia is a big reason why.

Shares of Generate Biomedicines Inc (NASDAQ:GENB) jumped more than 20% on Tuesday as investors positioned ahead of the expiration of the company's post-IPO lock-up period. The lock-up, which ends Wednesday, will free company insiders, early investors and major shareholders to sell shares...

Critical Metals is surging nearly 20% while its rare earth peers sit flat or slide lower, and no company announcement explains the gap. One unverified catalyst keeps surfacing in trader circles, and it has nothing to do with the ground under Greenland.

A veteran investor openly admits he wants SpaceX shares but refuses to touch them, and his reasoning points to a risk most retail investors are completely overlooking before the stock even opens for trading.

Editor’s Note: The story has been refreshed with the latest market price action and a revised headline. Anthropic’s reported potential $2 trillion valuation would require investors to underwrite an extraordinary combination of growth and margin expansion, while also taking lessons...

Anthropic has stayed silent on its IPO valuation, and that silence is doing serious work. Whatever number it prints will force analysts to reprice every AI-exposed stock from Amazon to Microsoft before the next bell rings.

PENGU token jumps 62% in a week as Luca Netz teases new milestones and traders revisit the Pudgy Penguins IPO goal.

Yahoo Finance Executive Editor Brian Sozzi sits down with Olipop co-founder and former CEO Ben Goodwin to discuss why traditional full-calorie soda might be a thing of the past, and how Olipop reclaimed the top spot in the category after PepsiCo's acquisition of rival Poppi. Ben Goodwin was still CEO of Olipop at the time of filming.

Anthropic’s reported potential $2 trillion valuation would require investors to underwrite an extraordinary combination of growth and margin expansion, while also taking lessons from Space Exploration Technologies Corp.‘s (NASDAQ:SPCX) turbulent transition from private-market darling to public company, says Dr Chan...

Anthropic's (ANTH.PVT) IPO paperwork could be filed as soon as this month, potentially beating OpenAI (OPAI.PVT) to the punch. Yahoo Finance Technology Editor Dan Howley outlines what we know so far.

Investing.com -- On Thursday, Bloomberg reported that Anthropic wants its planned IPO to match or exceed SpaceX’s nlockbuster offering, potentially setting up the largest public share sale in history.

Circle Internet (NYSE:CRCL) shares jumped 6. 0% in pre-market trading on Friday, extending their recent rally after the company announced the acquisition of a significant portion of IBM’s global blockchain patent portfolio.

Anthropic expects to match or beat the size of SpaceX's record-setting initial public offering, according to people familiar with the matter, in the latest sign of overwhelming demand from investors looking to profit from the artificial intelligence boom. Anthony Stephens has the latest.

Investing.com -- Anthropic PBC plans to match or exceed the size of SpaceX’s record-breaking initial public offering, Bloomberg reported on Thurdsay citing people familiar with the matter. The artificial intelligence company is advancing preparations for its stock market debut.

The Claude maker confidentially submitted a draft S-1 to the SEC and could file publicly as soon as the end of August

Unitree builds AI-powered robots that rival Tesla's Optimus units. Unitree raised more than $900 million with its IPO.

If humanoid robots are the future, then Elon Musk faces a formidable Chinese rival. China’s Unitree Robotics surged 460% on its trading debut in Shanghai Wednesday, giving the company a market capitalization of around $51 billion. Robots, of course, have been around for decades.

After its IPO, X-Energy's shares are up nearly 20% so far this month. Will they crush Oklo's?

The Hangzhou-based humanoid robot maker closed at 845 yuan on Wednesday, giving it a market value of around $50 billion

The company's struggling shares are launching back into orbit.